i n the last decades, spinal oncology has emerged as a separate subspecialty, 114 reflecting years of research focused on innovative techniques for controlling spinal tumors and managing the pain and pathophysiology arising from these types of cancers.
methods
The citation indexing service of Thomson Reuters Web of Science was queried. 103 The search algorithm ([spine OR spinal OR vertebral] AND [tumor OR neoplasm OR cancer OR metastases]) was used in the "Topic" field to identify articles of interest. The following search parameters were used: 1) articles published in the years 1864-2015, and 2) all languages. The articles retrieved were then sorted in descending order of times cited.
All authors then reviewed the article titles and abstracts to identify the 100 most-cited articles in the area of spinal oncology. Data such as title, authors, author specialty, journal of publication, year of publication, number of citations, article category, and country of origin were recorded. The levels of evidence of the studies were assigned according to therapeutic, prognostic, and diagnostic criteria set by the North American Spine Society (https:// www.spine.org/Portals/0/Documents/ResearchClinical Care/LevelsOfEvidence.pdf). Under these criteria, Level I studies correspond to high-quality randomized controlled trials or systematic reviews of Level I randomized trials; Level II studies correspond to lesser-quality randomized controlled trials, prospective comparative studies, or systematic reviews of Level II studies; Level III studies correspond to case-control studies, retrospective comparative studies, or systematic reviews of Level III studies; Level IV studies correspond to case series; and Level V studies correspond to case reports or expert opinions.
To control for year of publication, a citations per year (CY) index was calculated as follows: CY index = total number of article citations/years the article has been published (up to 2015).
results
Our search algorithm retrieved 157,468 articles, and the top 100 articles on topics related to spinal oncology were identified according to the number of times they were cited by other studies ( Table 1 ). The articles on this top 100 list were cited between 120 (article Nos. [96] [97] [98] [99] [100] and 1164 times (top article), and all 100 articles had been collectively cited 20,771 times (with a mean number of citations of 207.7 for each paper). The oldest article on the top 100 list was from 1931, and the most recent from 2008. Ninety-nine articles were written in English, and 1 was written in French. The list comprised 4 Level I evidence studies, 3 Level II evidence studies, 9 Level III evidence studies, 70 Level IV evidence studies, and 2 Level V evidence studies; levels of evidence were not assigned to 12 studies because they were not on therapeutic, prognostic, or diagnostic topics. The top article according to the CY index had been cited 55.2 times per year and was No. 5 on the top 100 list, and the bottom article had been cited 1.61 times per year (No. 72 on the top 100 list). The most prolific decade was the 1990s, with 34 articles on the top 100 list ( Table 2) .
The top 100 articles were published in 31 different journals, with the Journal of Neurosurgery contributing most studies (i.e., 25 articles), followed by Cancer and Spine, (each having published 12 articles on this list) ( Table 3 ). When we analyzed the articles by study scope and type, 67 were identified as clinical outcome studies (i.e., case series, retrospective cohort studies, prospective studies, and randomized controlled trials), 9 were review articles (including systematic reviews and meta-analyses), 6 were anatomical or pathological studies, 5 were technical notes, 4 were staging or prognostic studies, 4 were radiology studies, 2 were basic science or animal studies, 2 were case reports, and 1 was an epidemiological study. The most common article topics were spinal metastases (n = 35), followed by intramedullary tumors (n = 18), chordoma (n = 17), intradural tumors (n = 7), vertebroplasty or kyphoplasty (n = 7), primary bone tumors (n = 6), and others (n = 10).
The country with the highest number of articles on the top 100 list was the United States (n = 62), followed by Canada and France, with 8 and 7 articles each, respectively (Table 4 ). The author with the largest number of articles on the top 100 list was Fred J. Epstein (sometimes cited as Epstein, F.) with 6 articles, followed by K. D. Harrington (United States), Z. L. Gokaslan (United States), K. Tomita (Japan), N. Kawahara (Japan), S. Boriani (Italy), R. Biagini (Italy), and N. Sundaresan (United States), who each had authored or coauthored 3 articles on this list.
discussion
Spinal oncology has exponentially grown during the last decades, currently involves numerous specialties, and is considered by many a distinct subspecialty. 114 in this study, we sought to identify the most-cited 100 articles in spinal oncology, in an effort to gain insight into the history and future directions of spinal tumor research. Not surprisingly, we found that the top 100 most-cited articles were written by authors in a variety of specialties, including neurosurgery, orthopedic surgery, neurology, pathology, radiology, and radiation oncology. In contrast to other research fields in which most high-impact articles are published in only a few journals, 88 the most-cited articles pertaining to spinal oncology were published in 31 different journals, also reflecting the multidisciplinary nature of spinal tumor research.
The article that had received the most citations on our top 100 list was an anatomical pathology study by Oscar Vivian Batson, in which the author described a valveless venous system (now known as Batson's plexus) that connects the deep pelvic and thoracic veins to the vertebral venous plexus, a circulation system that most likely is involved in the spread of metastatic disease to the spine.
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This article was No. 1 on the list when ranked by the total number of received citations, but it was ranked No. 15 according to the CY index, with 15.52 citations per year since its publication in 1940. The second and third most-cited articles were by French authors, and both studies described vertebroplasty and kyphoplasty, techniques used to treat intractable pain and provide stability to osteoporotic or pathological compression fractures; 32,51 the description of vertebroplasty for spinal angiomas by Galibert and colleagues was the only article on the list in a language other than English (French in this case). These 2 articles were No. 2 and No. 3 also on the CY index list, and their high ranks on both lists support the assertion that both of these studies made a significant impact on the management of pathological compression fractures. Notably, vertebroplasty and kyphoplasty were also the focus of articles that were ranked No. 6 and 8 according to the CY index; in both studies, the authors examined the role of these techniques in the treatment of pathological fractures due to metastatic disease.
Two randomized controlled trials were among the top 10 articles on the top 100 list. A trial by Young et al. published in 1980 investigated the outcomes among patients with metastatic epidural spinal cord compression treated with laminectomy plus radiotherapy versus patients treated with radiotherapy alone; the authors reported that the 2 treatment modalities do not significantly differ in providing pain relief or in improving ambulation or sphincter function. 123 This trial led to the general belief that outcomes after radiotherapy alone can be equivalent to those after laminectomy without instrumentation. Several years later, Patchell and colleagues reported outcomes of "direct decompressive surgery," in which the pathological compression (most often located anteriorly to the spinal canal) was addressed anteriorly rather than posteriorly via a laminectomy. 87 The findings of this trial indicated a significant treatment difference: patients who underwent direct decompression plus radiotherapy were more likely to walk after treatment and retain the ability to walk longer distances than patients who underwent only radiation.
87
The study by Patchell et al. had received 552 citations, and was one of the few articles on our top 10 list published in a high-impact factor medical journal (The Lancet). More importantly, however, this article was ranked No. 1 according to the CY index, with 55.2 citations per year since its publication in 2005; this highlights the impact this study had on the management of metastatic epidural spinal cord compression.
Another noteworthy article on our top 10 list was the study by Tomita et al. (from Japan), which was ranked No. 7 on the regular list and No. 6 on the CY index list (with 27.36 citations per year since 2001), and in which the authors described a surgical strategy to approach spinal metastases. 112 This strategy was based on those reported in several other studies on the top 100 list, mainly the initial report of en bloc spondylectomy for spinal tumors also by Tomita et al. (articles No. 11 and 38) and of the Tokuhashi scoring system (article No. 16). When examining studies by research topic, we found that more than one-third of the articles had a focus on spinal metastases, a disease condition that is the most common type of spinal tumor and observed in 36% of patients who die of cancer.
120
The second most common topic among the 100 mostcited articles was intramedullary tumors. Although these tumors account for only 2%-4% of all CNS tumors, 95 18 articles on the topic of intramedullary tumors were on the top 100 list; these articles focused on outcomes after surgery for ependymoma, cavernous angioma, gliomas, and other tumors. Research focused on chordoma was the third most common area on the top 100 list, with 17 articles (articles No. 12, 13, 18, 20, 23, 26, 35, 36, 44, 53, 57, 64, 67, 78, 81, 98, and 99) investigating the genes involved in chordoma, outcomes after surgery or radiation for chordoma, epidemiology of this disease, and other chordoma-related topics. Chordoma has an estimated incidence of 0.08 per 100,000 cases, and is considered the most common primary malignant bone tumor of the sacrum and mobile spine.
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Although relatively rare, significant efforts have been directed toward identifying a cure for this disease. Current research has focused on stereotactic body radiotherapy, proton-beam therapy, and novel agents such as nilotinib, dasatinib, and imatinib (all tyrosine kinase inhibitors) to treat chordoma patients.
17,18
The most prolific decade was the 1990s with 34 articles. Eighty-three of the 100 articles were published after 1980; this observation is similar to findings by Steinberger et al. who examined the top 100 articles published on lumbar spine surgery. 103 The oldest article on our top 100 list was from 1931 by the Irish-American pathologist James Watson Kernohan and colleagues (article No. 72) , in which the authors described pathological findings of intramedullary tumors. 68 The most recent was from 2008 by radiation oncologist Yamada and colleagues (article No. 60), in which the authors examined the effect of high-dose, single-fraction, image-guided, intensity-modulated radiotherapy for local tumor control in patients with metastatic spinal lesions. 121 This article was No. 60 on the top 100 list and No. 9 according to the CY index (21.14 CY since 2008).
Although authors from the United States contributed most of the studies to the top 100 list (i.e., 62), it is of note that authors from 9 other countries also contributed. When we examined the articles for individual authors, we found that Fred J. Epstein was an author on 6 articles on the list, all focused on intramedullary tumors (articles No. 34, 47, 61, 63, 77, and 100); 7 other authors appeared 3 times each on this list.
According to the level-of-evidence grading, 70% of the articles were Level IV evidence studies, and only 4% were high-quality Level I evidence studies. Even though this observation implied scarce high-quality evidence for management of spinal tumors, the challenges of conducting randomized controlled surgical trials must be acknowledged. Such studies require multicenter collaborations, a lot of personnel, large funding, and patients' consent to receiving either an experimental intervention or no intervention. Additionally, we also observed very few Level III evidence studies (case-control studies or retrospective comparative studies), which may be the next step in spinal oncology research. Level III studies are less challenging to conduct than randomized trials, but they allow for multivariable analyses or direct comparison of interventions. We also note that the lower representation of higher-levelevidence studies on the top 100 list does not necessarily mean that these studies have not been frequently conducted-it may simply imply that these types of studies may have not been cited as many times as studies with lower levels of evidence.
To identify temporal trends in spinal tumor treatments, studies reporting on particular techniques were stratified by time published (Table 5) . Resection (either subtotal or gross total) was the main topic in articles published in the 1930s and 1940s, and the combination of surgery plus radiation therapy began to be reported in 1950. This treatment modality then became the mainstay of treatment for spinal tumors up to the 1990s when en bloc resection was shown to achieve superior outcomes compared with intralesional or subtotal resection. Likewise, the introduction of vertebroplasty and kyphoplasty did not happen until the 1980s. Last, frequently cited studies reporting on radiosurgery and photon therapy for spinal tumors were published in the 1990s and 2000s.
As mentioned above, spinal oncology is a dynamic field, and the articles identified in this study reflected that dynamism. Ranging from anatomical pathology studies to randomized controlled trials to systematic reviews, the top 100 most-cited articles focused on topics such as metastatic spinal tumors, primary vertebral column tumors, radiation oncology, surgical techniques, intramedullary tumors, staging and scoring systems, and many other areas. The fact that many distinct specialties and journals were represented among the studies on this list is very interesting and supports the notion that spinal tumors are best treated in a multidisciplinary and multimodal fashion.
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Advances in genetics-based treatments, 37 radiosurgery, 17 proton-beam therapy, 2,86 immunotherapy, 18 and minimally invasive surgery, 36, 38, 70, 81 among others, will be an important part of the future of spinal oncology. Treatments involving wild-type neurofibromatosis 2 gene insertion, oncolytic viruses, and transfer of gene-silencing ribonucleic acid have all shown promising results in vitro for meningiomas. 37 Stereotactic body radiotherapy (radiosurgery) has been used as a first-line treatment for metastatic lesions, after failure of conventional radiotherapy, after separation surgery, and as first-line treatment for primary tumors and has shown promising results in each approach. 17 Recently, proton-beam therapy has gained attention because it can deliver high doses of energy to a small tissue volume; clinical studies have shown high local tumor control and overall patient survival rates, particularly for chordoma.
80,86
The aforementioned tyrosine kinase inhibitors are currently being investigated for the treatment of chordoma; 18 other immunotherapeutic agents have also been investigated for metastatic melanoma to the spine. 20 Last, minimally invasive surgery has been shown to provide outcomes in terms of neurological recovery similar to outcomes of traditional open surgery for vertebral thoracic metastases causing acute myelopathy; 81 other studies have also examined the role of minimally invasive surgery on intradural tumors. 52 Although each of these techniques has shown favorable results, patients will most likely have best outcomes when treated by a multidisciplinary team that uses a combination of multimodal strategies.
limitations
This study has several limitations. First, some studies have suggested that citation analyses may favor older studies, since these studies had more time to accumulate citations. 56, 96 For example, it could be argued that clinical studies such as that by Patchell et al. 87 on direct decompressive surgery plus radiotherapy have much more clinical "impact" than the anatomical study by Batson, 8 and yet the latter had more than double the number of citations. For this reason, in an attempt to control for this potential bias, we utilized the CY index. When we ranked the studies according to the CY index, the study by Patchell et al. jumped to No. 1, and the top 10 articles on the CY list included those on topics such as vertebroplasty/ kyphoplasty, radiotherapy, and radiosurgery. Second, although Web of Science has been used for citation analysis, we note that this index does not always include citations from textbooks or journals written in languages other than English.
88 Third, although we ranked articles by number of citations, we excluded some studies in a subjective manner, and it may be possible that other relevant articles were missed. Last, the number of times an article has been cited does not directly reflect its quality. As shown in this study, most articles were Level IV evidence studies, and only 4 were Level I evidence studies. conclusions in this study, the 100 most-cited articles in spinal oncology were examined, and important contributions from various authors, specialties, and countries were identified. More than one-third of the research in these articles was focused on spinal metastases, followed by intramedullary tumors and chordoma. The top 100 articles were published in 31 different journals, reflecting the multidisciplinary nature of spinal tumor care. Recognition of important historical contributions to this field may guide future investigations into spinal oncology.
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